{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:07:21Z","timestamp":1792260441881,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer&apos;s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer&apos;s Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE HealthCare Technologies Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.parkreldis.2026.108265","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T20:37:36Z","timestamp":1772483856000},"page":"108265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multimodal biomarkers to predict dementia-free survival and cognitive decline in mild cognitive impairment with Lewy bodies"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0989-1175","authenticated-orcid":false,"given":"Jahfer","family":"Hasoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-3150","authenticated-orcid":false,"given":"Calum A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-0185","authenticated-orcid":false,"given":"Michael","family":"Firbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Colloby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7195-4846","authenticated-orcid":false,"given":"Paul C.","family":"Donaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108265_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","article-title":"Survival time and differences between dementia with lewy bodies and Alzheimer's disease following diagnosis: a meta-analysis of longitudinal studies","volume":"50","author":"Mueller","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108265_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/gps.4015","article-title":"Time until nursing home admission in people with mild dementia: comparison of dementia with lewy bodies and Alzheimer's dementia","volume":"29","author":"Rongve","year":"2014","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108265_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","article-title":"The prognosis of dementia with lewy bodies","volume":"16","author":"Mueller","year":"2017","journal-title":"Lancet Neurol."},{"issue":"22","key":"10.1016\/j.parkreldis.2026.108265_bib5","doi-asserted-by":"crossref","first-page":"e2685","DOI":"10.1212\/WNL.0000000000012024","article-title":"Progression to dementia in mild cognitive impairment with lewy bodies or alzheimer disease","volume":"96","author":"Hamilton","year":"2021","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.parkreldis.2026.108265_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with lewy bodies","volume":"94","author":"McKeith","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-130842","article-title":"Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors","volume":"38","author":"Peters","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.bp.110.077958","article-title":"Predicting outcome in mild cognitive impairment: 4-year follow-up study","volume":"197","author":"Lonie","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000113014","article-title":"Predicting rapid clinical progression in amnestic mild cognitive impairment","volume":"25","author":"Ahmed","year":"2008","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108265_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.neurobiolaging.2010.01.022","article-title":"Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease","volume":"31","author":"Liu","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jns.2014.09.012","article-title":"Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition","volume":"346","author":"Tokuchi","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108265_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021896","article-title":"I. the Alzheimer's Disease neuroimaging, identification of conversion from mild cognitive impairment to Alzheimer's Disease using multivariate predictors","volume":"6","author":"Cui","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2013.06.018","article-title":"Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia","volume":"35","author":"Trzepacz","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2026.108265_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101771","article-title":"Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging","volume":"22","author":"Ottoy","year":"2019","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.parkreldis.2026.108265_bib15","article-title":"Prediction models for conversion from mild cognitive impairment to Alzheimer's Disease: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108265_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2020.101848","article-title":"Predicting the progression of mild cognitive impairment using machine learning: a systematic, quantitative and critical review","volume":"67","author":"Ansart","year":"2021","journal-title":"Med. Image Anal."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108265_bib17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1017\/S1041610221001083","article-title":"Slowing on quantitative EEG is associated with transition to dementia in mild cognitive impairment","volume":"33","author":"Hamilton","year":"2021","journal-title":"Int. Psychogeriatr."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108265_bib18","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1212\/WNL.0000000000009977","article-title":"Diagnostic and prognostic value of EEG in prodromal dementia with lewy bodies","volume":"95","author":"van der Zande","year":"2020","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.parkreldis.2026.108265_bib19","doi-asserted-by":"crossref","first-page":"e2413","DOI":"10.1212\/WNL.0000000000200326","article-title":"Brain metabolism related to mild cognitive impairment and phenoconversion in patients with isolated REM sleep behavior disorder","volume":"98","author":"Yoon","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108265_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/mds.27997","article-title":"Prodromal Dementia with lewy bodies: clinical characterization and predictors of progression","volume":"35","author":"van de Beek","year":"2020","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108265_bib21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108265_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jagp.2019.12.009","article-title":"Amyloid imaging and longitudinal clinical progression in dementia with lewy bodies","volume":"28","author":"Donaghy","year":"2020","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108265_bib23","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209418","article-title":"Association of plasma amyloid, P-Tau, GFAP, and NfL with CSF, clinical, and cognitive features in patients with dementia with lewy bodies","volume":"102","author":"Bolsewig","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2026.108265_bib24","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291725100895","article-title":"Progression of clinical diagnostic features and cognitive decline in mild cognitive impairment with lewy bodies","volume":"55","author":"Hamilton","year":"2025","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.parkreldis.2026.108265_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/mds.30181","article-title":"Plasma biomarkers and disease prognosis in mild cognitive impairment with lewy bodies","volume":"40","author":"Donaghy","year":"2025","journal-title":"Mov. Disord."},{"issue":"14","key":"10.1016\/j.parkreldis.2026.108265_bib26","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1017\/S0033291717003956","article-title":"Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with lewy bodies","volume":"48","author":"Donaghy","year":"2018","journal-title":"Psychol. Med."},{"issue":"22","key":"10.1016\/j.parkreldis.2026.108265_bib27","doi-asserted-by":"crossref","first-page":"e2685","DOI":"10.1212\/WNL.0000000000012024","article-title":"Progression to dementia in mild cognitive impairment with lewy bodies or alzheimer disease","volume":"96","author":"Hamilton","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108265_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on aging-alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's Dement."},{"issue":"5","key":"10.1016\/j.parkreldis.2026.108265_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1192\/bjp.2020.234","article-title":"Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with lewy bodies","volume":"218","author":"Ali","year":"2021","journal-title":"Br. J. Psychiatr."},{"issue":"23","key":"10.1016\/j.parkreldis.2026.108265_bib30","doi-asserted-by":"crossref","first-page":"e2801","DOI":"10.1212\/WNL.0000000000012060","article-title":"Accuracy of Cardiac innervation scintigraphy for mild cognitive impairment with lewy bodies","volume":"96","author":"Roberts","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2026.108265_bib31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/gps.1610","article-title":"The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening","volume":"21","author":"Mioshi","year":"2006","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108265_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S1041610214000416","article-title":"Review of brief cognitive tests for patients with suspected dementia","volume":"26","author":"Velayudhan","year":"2014","journal-title":"Int. Psychogeriatr."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S1041610212001500","article-title":"Attitudes of UK psychiatrists to the diagnosis of MCI in clinical practice","volume":"25","author":"Rodda","year":"2013","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-020-00650-1","article-title":"Quantitative EEG as a biomarker in mild cognitive impairment with lewy bodies","volume":"12","author":"Schumacher","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneumeth.2003.10.009","article-title":"EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis","volume":"134","author":"Delorme","year":"2004","journal-title":"J. Neurosci. Methods"},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108265_bib36","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s00415-020-10271-1","article-title":"Mild cognitive impairment with lewy bodies: blood perfusion with arterial spin labelling","volume":"268","author":"Firbank","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2026.108265_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2021.03.011","article-title":"Hippocampal and insula volume in mild cognitive impairment with lewy bodies","volume":"86","author":"Firbank","year":"2021","journal-title":"Park. Relat. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2026.108265_bib38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/01.WNL.0000086375.33512.53","article-title":"Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects","volume":"61","author":"Firbank","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108265_bib39","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hbm.20480","article-title":"Validation of a fully automated hippocampal segmentation method on patients with dementia","volume":"29","author":"Firbank","year":"2008","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3397","article-title":"Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia","volume":"14","author":"Persson","year":"2024","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.parkreldis.2026.108265_bib41","series-title":"MATLAB Version: 9.12.0.2009381 (R2022A) Update 4","year":"2022"},{"issue":"3","key":"10.1016\/j.parkreldis.2026.108265_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaike's Information Criterion (AIC): the general theory and its analytical extensions","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"issue":"16","key":"10.1016\/j.parkreldis.2026.108265_bib43","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1017\/S0033291723001952","article-title":"Plasma biomarkers of neurodegeneration in mild cognitive impairment with lewy bodies","volume":"53","author":"Hamilton","year":"2023","journal-title":"Psychol. Med."},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108265_bib44","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.parkreldis.2026.108265_bib45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181bacf9e","article-title":"Relative preservation of MMSE scores in autopsy-proven dementia with lewy bodies","volume":"73","author":"Nelson","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2026.108265_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5839","article-title":"Disease progression in dementia with Lewy bodies: a longitudinal study on clinical symptoms, quality of life and functional impairment","volume":"37","author":"van de Beek","year":"2022","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"2","key":"10.1016\/j.parkreldis.2026.108265_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with lewy bodies","volume":"88","author":"Lemstra","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2026.108265_bib48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.07.005","article-title":"Gray matter atrophy in dementia with lewy bodies with and without concomitant Alzheimer's disease pathology","volume":"71","author":"van der Zande","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2026.108265_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2026.108265_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1570553","article-title":"\u03b1-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies","volume":"19","author":"Padilla-God\u00ednez","year":"2025","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2026.108265_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab269","article-title":"Brain atrophy progression in Parkinson's disease is shaped by connectivity and local vulnerability","volume":"3","author":"Tremblay","year":"2021","journal-title":"Brain Commun"},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108265_bib53","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/mds.28077","article-title":"Magnetic susceptibility associates with dopaminergic deficits and cognition in Parkinson's Disease","volume":"35","author":"Uchida","year":"2020","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2026.108265_bib54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/mds.27717","article-title":"Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment","volume":"34","author":"Uchida","year":"2019","journal-title":"Mov. Disord."},{"issue":"7611","key":"10.1016\/j.parkreldis.2026.108265_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"Bmj"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802026000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:46:57Z","timestamp":1777610817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802026000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":55,"alternative-id":["S1353802026000921"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108265","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal biomarkers to predict dementia-free survival and cognitive decline in mild cognitive impairment with Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108265"}}